No plans to inject computing power assets! A nine-day limit-up ST stock issues an unusual trading activity announcement | Post-market announcement highlights

Nine consecutive limit-ups *ST Zhunyou: The company, its controlling shareholder, and actual controller have no plans to inject computing power assets.

cls.cnMay 17 18:32

Ellis Shareholders' Meeting: Heavy reliance on a single blockbuster product, with more growth anxieties to address amid the looming patent cliff.

① Once the growth dividend of Fumetinib begins to taper off, whether there will be a successor product and where Alis's "next Fumetinib" lies have become key focal points for the market; ② The domestic patent for the Fumetinib compound is set to expire in 2034, while the domestic patent for Methanesulfonic Acid Fumetinib (salt) will expire in 2036. **This implies that the existing patent protection barrier will vanish by then, and Alis may no longer enjoy the high gross profit margin associated with its original drug.**

cls.cnMay 16 21:41

The 'Token Factory' achieves real-world implementation: Operators initiate large-scale procurement worth tens of billions, while major companies accelerate their strategic positioning.

① Ningxia Branch of China Telecom released the centralized procurement project for the "Token Factory" generation capability service, marking the first large-scale procurement project named after the Token Factory among the three major telecom operators, valued at the billion-dollar level. ② The Token Factory is considered "the business model with the fastest short-term growth for model vendors and the most certain commercialization potential in its early stages." ③ Baidu recently announced that Baidu Intelligent Cloud will upgrade its "MaaS Model Service" to the "Token Factory."

cls.cnMay 16 13:42

Heartbeat Medical's Shareholders' Meeting: Pre-meeting Discussions, On-site Exhibitions, and Executives Surrounded with Questions on 'Future Path'

①This hour-long discussion primarily focused on the following issues: Where is the next major product opportunity? Is there further room for price reductions for the Castor stent? How to break through the current situation? ②How to transform into a more commercially efficient and mature enterprise while maintaining its technological foundation will be the biggest highlight for this 'star of the MicroPort Group' in the next phase.

cls.cnMay 15 23:24

Persistent increase in sales expenses? G-bits responds: There is a cycle for buyback of traffic, and we focus more on total profit than ROI | Earnings call highlights

① G-bits held an earnings briefing today. Regarding the sharp increase in sales expenses, the company stated that user acquisition spending has a certain payback period—initial marketing outlays are first reflected in expenses and only gradually translate into revenue and profit over time. ② The company also noted that it has widely adopted AI across game development, creative production, and publishing. It believes the key to addressing rising user acquisition costs and the impact of AI lies in delivering fresh and engaging experiences to players.

cls.cnMay 15 22:25

The inclusion of data assets on balance sheets is accelerating, with leading enterprises already surpassing hundreds of millions in scale. Urban investment companies are leveraging this to secure additional financing.

① A total of 134 companies disclosed data resource-related entries in their 2025 annual reports, with a combined entry value reaching 3.86 billion yuan. In contrast, there were only 91 companies in 2024, with entry values falling short of 2 billion yuan. ② Data asset financing is not merely an innovation in a single financial instrument but rather a systematic project involving property rights systems, valuation frameworks, financial products, regulatory coordination, and ecosystem services.

cls.cnMay 15 15:14